NCT03642496 2018-08-23Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell MalignanciesFirst Affiliated Hospital Xi'an Jiaotong UniversityPhase EARLY_PHASE1 Unknown18 enrolled